COMPANY PROFILE

Jade Biomedical

Explore full profile

Provides expert Quality, Regulatory and Analytical Testing Services to Biopharmaceutical companies worldwide

Suzhou Shi, ChinaBiotech & Life Sciences

Valuation $100–250M Last recorded · 2022

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Jade Biomedical

JADE Biomedical, based in China, is a leading provider of Chemistry, Manufacturing, and Controls (CMC) services, along with Global Good Manufacturing Practice (GMP) compliant quality services and contract testing for the biopharmaceutical industry. The company serves a diverse range of clients, including emerging Chinese biopharmaceutical companies and global firms looking to expand into the Chinese market. JADE Biomedical's business model focuses on supporting the establishment of GMP manufacturing and product quality infrastructure, aiding in the clinical development and initial product launch phases. The company generates revenue through its comprehensive suite of services, which are critical for ensuring compliance with international quality standards and facilitating market entry.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Headquarters: Suzhou Shi, China
Employees: 6
Open positions: None listed
Dealroom signal: 26.2/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Sep 2022	$20M	$80M	Panacea Venture · VMS Investment Group	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Jade Biomedical website traffic

Latest recorded traffic for Jade Biomedical is 160 monthly website visits, up 6.7% over the last three months. Jade Biomedical's team grew 0% over the past year.

Latest monthly visits160 3-month web change+6.7% 1-year team growth0%

Monthly website visitsDec 2022–Nov 2023

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HTHarness TherapeuticsA private biotechnology company, headquartered in Cambridge-UK, focused on the development of a novel class of therapeutic RNAs	Babraham, United Kingdom	Operational	5	$35M	$90M
KIKimialysDeveloper of an analytical device intended to offer products based on innovative surface chemistry in the field of biosensors	Paris, France	Operational
SISideROSFocused on accelerated development of innovative small molecules targeting tumour cells metabolism in high-risk cancers	Paris, France	Closed
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational
BPBrenus PharmaProducing the widest panel of tumor associated antigens and resistance markers with a chemical labeling enable to induce cell death by patients' immune system	Clermont-Ferrand, France	Operational
EBExeliom BiosciencesDeveloping single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics	Dijon, France	Operational
AVAvantGuardAvantGuard (formerly Halomine) manufactures and supplies high-performance and human-friendly antimicrobial coating materials and technology	Ithaca, United States	Operational
HPHcs PharmaA company specializing in cell imaging	Loos, France	Operational